medigraphic.com
ISSN 1561-302X (Print)

2013, Number 3

<< Back Next >>

Rev cubana med 2013; 52 (3)

Influence of history of diabetes mellitus on the severity of stroke in hypertensive patients

Fernández GB, Tárano BD, Arteaga ÁM, Rodríguez ML

Language: Spanish
References: 17
Page: 189-196
PDF size: 56.48 Kb.


ABSTRACT

Background: An observational, cross-sectional study was conducted.
Objective: To determine the influence of history of diabetes mellitus on the severity of neurological and functional manifestations in hypertensive patients who have suffered from a stroke.
Methods: a study was conducted from 2007 to 2012 in 49 patients form the International Center of Neurological Restoration, with the diagnosis of stroke of more than 6 months of evolution. They were grouped in diabetic hypertensive and non-diabetic hypertensive patients. Comparisons between the two groups were made according to vascular risk factors (age, body mass index, sex, ischemic and valvular heart disease, dyslipidemia, smoking, atrial fibrillation, and hyperuricemia) and clinical scales (Scandinavian Stroke Scale, Barthel index scale and modified Rankin scale).
Results: the groups under study did not present significant differences in relation to vascular risk factors, except the significant presence of dyslipidemia in the group of diabetic hypertensive patients (p=0,01). The value of the scales used was higher, but not significant in diabetic hypertensive patients (p›0,05), suggesting a similar behavior of the neurological and functional conditions in both groups. The values of glycemia and systolic and diastolic pressures, did not show relevant differences in the groups (p›0,05), existing an appropriate control of glycemic indexes for the diabetes mellitus (6,54±2,24 mmol/l) and an average inadequate control of the indexes of blood pressure in both groups (systolic pressure> 130 mm of Hg, diastolic pressure › 80 mm of Hg).
Conclusions: the antecedent of diabetes mellitus in hypertensive patients that have suffered from a stroke, with more than 6 months of evolution, does not influence on the severity of both neurological and functional conditions.


REFERENCES

  1. Cabrera Rode E, Suárez Fonseca L, Díaz Orta O, Díaz Díaz O. Nuevos criterios para clasificar la diabetes mellitus. Rev Cubana Endocrinol. 2000;11(1):51-5.

  2. Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 1 Jun. 2010;121(21):2271-83.

  3. Kittner SJ, Singhal AB. Premature atherosclerosis: A major contributor to early-onset ischemic stroke. Neurology. 2 Abr 2013r;80(14):1272-3.

  4. Kuwashiro T, Sugimori H, Ago T, Kuroda J, Kamouchi M, Kitazono T. The impact of predisposing factors on long-term outcome after stroke in diabetic patients: the Fukuoka Stroke Registry. Eur J Neurol. 9 Feb 2013.

  5. Kuwashiro T, Kamouchi M, Ago T, Hata J, Sugimori H, Kitazono T. The factors associated with a functional outcome after ischemic stroke in diabetic patients: the Fukuoka Stroke Registry. J Neurol Sci. 15 Feb 2012;313(1-2):110-4.

  6. Cordero A, Lekuona I, Galve E, Mazón P. Novedades en hipertensión arterial y diabetes mellitus. Rev Esp Cardiol. 2012;65 (supl 1): 12-23.

  7. Megherbi SE, Milan C, Minier D, Couvreur G, Osseby GV, Tilling K, et al; European BIOMED Study of Stroke Care Group. Association between diabetes and stroke subtype on survival and functional outcome 3 months afterstroke: data from the European BIOMED Stroke Project. Stroke. 2003 Mar;34(3):688-94.

  8. Barber M, Fail M, Shields M, Stott DJ, Langhorne P. Validity and reliability of estimating the scandinavian stroke scale score from medical records. Cerebrovasc Dis. 2004;17(2-3):224-7.

  9. Sangha H, Lipson D, Foley N, Salter K, Bhogal S, Pohani G, et al. A comparison of the Barthel Index and the Functional Independence Measure as outcome measures in stroke rehabilitation: patterns of disability scale usage in clinical trials. Int J Rehabil Res. Jun 2005;28(2):135-9.

  10. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. Mar 2007;38(3):1091-6.

  11. Weng WC, Huang WY, Su FC, Chien YY, Wu CL, Lee TH, et al. Less favorable neurological recovery after acute stroke in patients with hypercholesterolemia. Clin Neurol Neurosurg. 15 Feb 2013. pii: S0303-8467(13):00041-3.

  12. Lee M, Saver JL, Hong KS, Song S, Chang KH,

  13. Ortega Casarrubios MA, Fuentes B, San José B, Matínez P, Díez Tejedor E. Influencia del antecedente de diabetes mellitus en la gravedad y la evolución intrahospitalaria de un infarto cerebral. Neurología. 2007;22 (7):426-33.

  14. Yu J, Shah BM, Ip EJ, Chan J. A markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from kaiserpermanente northern california. J Manag Care Pharm. Mar 2013;19(2):102-14.

  15. Norrving B, Kissela B. The global burden of stroke and need for a continuum of care. Neurology. 15 Ener 2013;80(3 Suppl 2):S5-12.

  16. American Diabetes Association. Standards of Medical Care in Diabetes 2009. Diabetes Care. 2009;32(Suppl 1):S13-S61.

  17. Llibre Rodríguez J, Laucerique Pardo T, Noriega Fernández L, Guerra Hernández M. Prevalencia de hipertensión arterial, adhesión al tratamiento y su control en adultos mayores. Rev Cubana Med [revista en Internet]. Sep 2011 [citado 29 Mar 2013]; 50(3): 242-251. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034 -75232011000300003&lng=es&nrm=iso&tlng=es




2020     |     www.medigraphic.com